Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$262.75 - $319.31 $315,300 - $383,172
1,200 New
1,200 $374,000
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $5.88 Million - $6.63 Million
-23,000 Reduced 86.79%
3,500 $1.01 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $3.54 Million - $4.4 Million
16,200 Added 157.28%
26,500 $7.12 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $25.8 Million - $30.5 Million
-120,200 Reduced 92.11%
10,300 $2.29 Million
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $16.1 Million - $19.6 Million
-71,200 Reduced 35.3%
130,500 $31.5 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $16.6 Million - $21.1 Million
72,500 Added 56.11%
201,700 $53 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $25.5 Million - $28.8 Million
113,800 Added 738.96%
129,200 $29.1 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $9.02 Million - $10 Million
-39,100 Reduced 71.74%
15,400 $3.75 Million
Q1 2022

May 17, 2022

BUY
$219.27 - $242.57 $12 Million - $13.2 Million
54,500 New
54,500 $13.2 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $1.99 Million - $2.28 Million
-10,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $191,043 - $223,830
-900 Reduced 8.26%
10,000 $2.13 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $37.6 Million - $41.7 Million
-161,100 Reduced 93.66%
10,900 $2.66 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $38.2 Million - $44.5 Million
172,000 New
172,000 $42.8 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $1.32 Million - $1.57 Million
-6,100 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $5.61 Million - $6.24 Million
-23,900 Reduced 79.67%
6,100 $1.55 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $4.95 Million - $6.07 Million
25,000 Added 500.0%
30,000 $7.08 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $946,050 - $1.22 Million
5,000 New
5,000 $1.21 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.